ABSTRACT: The purpose of this study was to determine whether an association existed between self-reported symptom and function scores and tissue turnover or inflammatory biomarker changes after a running bout among individuals with and without an acute knee-injury history. A pre-test/post-test prospective cohort study design (Level II) of 22 participants was conducted. Eleven physically active individuals with a history of anterior cruciate ligament surgery and/or meniscus surgery within 4 years of study participation were matched to 11 healthy control participants. All participants completed self-reported outcome measures (Knee Osteoarthritis Outcomes Score and Tegner activity level) assessing knee symptoms and functional levels prior to the run. Blood samples were taken both pre-and post-30-minute run at a prescribed pace on a treadmill to determine serum biomarker concentration changes. Tegner activity levels were inversely related to type II collagen/type II collagen synthesis marker ratio biomarker changes after the run (r ¼ À0.45, p ¼ 0.01). Quality-of-life scores pre-exercise were inversely related to interleukin-1b changes after the run (r ¼ À0.50, p ¼ 0.02). No other correlation coefficients were statistically significant (r ¼ À0.39 to 0.36). Ultimately, individuals with lower activity and quality-of-life scores experienced greater increases in collagen turnover and inflammation after a running bout, respectively. A gradual increase in activity (e.g., frequency, duration, intensity) may be warranted in this group prior to returning to activities that involve running. ß
Participation in certain sports 1 and/or a knee-injury history 2, 3 is linked to an increased prevalence of knee osteoarthritis (OA). Nearly all physically active individuals (e.g., athletes) with anterior cruciate ligament (ACL) or meniscal injuries return to pre-injury weightbearing activities within 1-year post-injury. 4 However, there is evidence that the knee biomechanics and biochemical environment of the physically active participant with a knee-injury history has not returned to baseline levels within 1-4 years post-injury. 5 Despite these individuals reporting low levels of function in sport and recreation and quality of life, most attempt to return to previous activities, with only 55% returning to their pre-injury activity levels. 6 The relationship between patient-reported outcomes, structural integrity, joint loading, and abnormal biochemical concentrations may be more than a simple cycle that is compounded by the desire to return to activity.
The existence of abnormal biomarker responses to exercise may likely indicate an active healing process and that joint tissues may not be ready to effectively respond or successfully adapt to the biomechanical loads (e.g., intensity, levels) to which they are being exposed. Serum cartilage oligomeric matrix protein (COMP) concentrations increase after walking at a selfselected pace in the OA and healthy populations, 7, 8 and increase even greater after various running intensities and durations in the healthy population. [9] [10] [11] [12] While increases in serum COMP after physical activity may be a potential prognostic indicator of OA progression, 13 it remains unclear why some individuals experience excessive increases and others do not. Individuals who report greater symptoms or lower activity levels may be experiencing adverse biomarker concentrations or responses to physical activity. Unfortunately, the relationship between symptoms and biomarker response to activity is unknown. We recently found that individuals with and without a knee-injury history had similar responses to a running bout, although the individual responses were varied. 14 The current study's secondary analysis of this data set focused on determining whether participants with a knee-injury history and control participants' self-reported outcome measures of symptoms, function, and physical activity level correlate with serum biomarker concentration changes after an acute running bout.
METHODS
A pre-test/post-test prospective cohort study design (Level II) was utilized to determine the relationship between selfreported outcome measures and biomarker changes in response to an acute running bout in participants with and without a knee-injury history. The dependent variables were pre-exercise self-reported outcomes as assessed by the five subscales of the Knee Osteoarthritis Outcomes Score (KOOS) and current Tegner Activity Scale scores, as well as serum concentrations changes pre-to post-running bout for three collagen turnover serum biomarkers: Cartilage oligomeric matrix protein (COMP); c-terminal cross linking telopeptide of type II collagen (CTX-II); type II collagen fragments (CPII); CTX-II/CPII ratios; one inflammatory biomarker: Interleukin (IL)-1b; and one biomarker of bone and cartilage degeneration: Matrix metalloproteinase (MMP)-13 (also known as Collagenase 3).
Participant enrollment in the study began in January 2014 and concluded in April 2014. Participant inclusion criteria for the study included being (i) 18-25 years of age; (ii) within a 1-h drive of the study research laboratories, and (iii) moderately physically active (Tegner Activity Scale !5). Knee-injury history participant inclusion criteria included medical clearance for return to physical activity following an acute knee injury (i.e., ACL or meniscus) and required surgical treatment (i.e., ACL reconstruction, meniscectomy, meniscal repair) within 4 years of study participation. Knee injury was verified through review of magnetic resonance imaging reports, imaging, or surgical notes. Knee-injury history exclusion criteria included self-reported diagnosed arthritis (e.g., rheumatoid) or a history of intra-articular injection within 30 days preceding the study. Control participants were recruited and matched to knee-injury history participants by age (AE2 years), gender (same), mass (AE6 kg), height (AE5 cm), and sport/physical activity level (same level of impact and risk of injury). Sport/physical activity levels were determined based on level of impact and risk of injury: Low, medium, or high. 1 Exclusion criteria for control participants were any self-reported arthritis (e.g., OA, rheumatoid) or prior significant lower extremity injury (i.e., missed physical activity for >2 weeks, use of crutches for >1 week). Two university institutional review boards approved the study prior to study participation. Participants completed approved informed consent and Health Insurance Portability and Accountability Act forms.
A standardized exercise protocol was followed. Each participant completed the KOOS and Tegner Activity Scale, and was fitted with a heart rate monitor (Polar, Lake Success, NY). Each participant then sat in a semi-recumbent position for 30 min, allowing for biomarker normalization from activities of daily living. The participant's blood was drawn after the 30-min rest period. Data collection occurred during the morning hours (between 7 and 9 am) to allow for biomarker standardization.
A certified phlebotomist followed standard Certified Venous Access Specialist protocol during antecubital venous blood draws (7 ml). The area was cleaned with isopropyl alcohol, then the needle was inserted and blood was drawn into a chilled 7 ml EDTA vacutainer tube. The blood sample was then centrifuged within 10 min at 1,000 rpm for 20 min at 4˚C, and the serum was transferred to cryovials with unique participant identity codes and stored at À80˚C until analysis.
The exercise protocol for the current study was replicated from a previous study in a healthy population that found COMP changes after an acute running bout 12 and consisted of the participants running at 2.2 m/s for 30 min. Safety measures included monitoring heart rate and rate of perceived exertion every 5 min during the running task. Exercise termination was not necessary in any participant due to excessive heart rate or rate of perceived exertion during the exercise bout (i.e., 90% of his/her estimated maximal heart rate and/or rate of perceived exertion of nine or higher 15 ). The participant returned to the research laboratory upon completion of the running task for the post-exercise blood draw, which was performed identical to the pre-exercise blood draw. Post-exercise blood draw was completed within 7 min after the exercise bout.
The KOOS subscale scores were utilized to assess a participant's perception of their knee health. It consists of five subscales (i.e., pain, symptoms, activities of daily living, sports and recreation function, and quality of life), and a higher score indicates better function or quality of life, or less severe symptoms. 16 The KOOS has high validity and high reliability and has been utilized in post-injury cohorts. 16 The Tegner Activity Scale score was used to assess physical activity level. The participant selected a number ranging from 0 to 10 that corresponded with the highest level of activity that she/he was currently participating (e.g., 0 ¼ sick leave or disability pension because of knee problems, 5 ¼ recreational sports-jogging on uneven ground at least twice a week, 10 ¼ competitive sports-soccer, football, rugby at the national elite level). A higher Tegner score indicates a higher level of physical activity and function. The Tegner Activity Scale also has high validity and reliability in a postknee-injury cohort. 17 When conducting biomarker analyses, serum samples were thawed and serum concentrations were quantified using commercially available enzyme-linked immunosorbent serologic assay kits. All assays were completed by one researcher who was blinded to self-reported outcome scores and knee-injury history status. The specific biomarker kits used in the study and the sensitivity and variance percentages were as follows: COMP (<1.0 pg/ml, <9%) from MyBioSource San Diego (catalog # MBS160044), CTX-II (II <3.7 ng/ ml, <15%) from MyBioSource San Diego (catalog # MBS816607); CPII (<11 ng/ml, <5%) from IBEX Pharmaceuticals, Montreal, Quebec, Canada (catalog # E2179h); IL-1b (<1.0 pg/ml, <10%) from Abcam Inc., Cambridge (catalog # ab46052), and MMP-13 (<4.8 pg/ml, <10%) from Abcam Inc. (catalog # ab100605).
RESULTS
Statistical analyses consisted of descriptive and inferential statistics. Data were analyzed using SPSS for Windows Version 21.0 statistical program (SPSS, Inc., Chicago, IL). Statistical significance was defined a priori as p 0.05. Serum biomarker concentrations were analyzed for normality and to ensure that appropriate assumptions for parametric test statistics were met. The concentrations were not normally distributed based on A Shapiro-Wilk's Test and a visual inspection of Q-Q and box plots, which is relatively common in serum biomarker research. 10 The appropriate nonparametric statistical tests (i.e., Wilcoxon Signed Rank Tests, Spearman rank correlation) were accordingly used. Wilcoxon Signed Rank Tests paired analyses were chosen to statistically control for participant matching on gender, age, height, weight, body mass index, and sport/activity risk level and were used to determine whether individuals with or without kneeinjury history had different self-reported outcomes. Spearman's rank correlations were conducted to assess the association between self-reported outcomes and biomarker changes in response to running.
Descriptive data for all 22 participants are presented in Table 1 . We previously reported that there were no significant differences in biomarker changes between the two groups. 14 The analysis of self-reported OUTCOMES AND RUNNING BIOMARKER CHANGES outcomes revealed that individuals with knee-injury history had significantly lower KOOS subscale scores for pain, symptoms, activities of daily living, sport/ recreation, and quality of life compared to their matched, healthy control ( Table 2) . No other group differences were statistically significant. The correlation coefficients for pre-exercise self-reported outcome measures and post-exercise biomarker changes are reported in Table 3 . Pre-exercise reports of current Tegner activity levels showed significant moderate negative correlations to CTX-II/CPII ratio biomarker changes post-exercise (r ¼ À0.45, p ¼ 0.01). Pre-exercise KOOS quality-of-life scores showed significant moderate negative correlations to IL-1b changes (r ¼ À0.50, p ¼ 0.02) post-exercise. No other correlation coefficients were statistically significant (r ¼ À0.39 to 0.36). Injury type (i.e., isolated ACL, ACL with meniscal injury), time since injury/return to activity, and height were covariates considered that did not yield any significant changes in analysis results.
DISCUSSION
Self-reported outcome scores may serve as prognostic indicators by relating to underlying biomarker concentrations or differences in response to exercise bouts. Previously it had been reported that there was a positive relationships between resting serum COMP levels and self-reported patient outcome scores in the Lysholm and International Knee Documentation Committee scores during the course of a season within a soccer cohort. 18 While there is limited research within sports medicine literature regarding self-reported outcomes and their relationship to underlying biochemical concentrations, this is the first study to investigate the relationship between patient-reported outcome measures and serum biomarker response to an acute running bout in college-aged participants with and without a knee-injury history.
In this current study, participants with a kneeinjury history had lower pre-exercise functional, quality of life, and greater pain scores compared to their matched healthy controls, despite the previously reported lack of biomarker differences between groups. Additionally, lower pre-exercise quality of life and current Tegner physical activity level were associated with greater inflammatory response (IL-1b) and collagen turnover (CTX-II/CPII ratio), respectively.
Participants with a knee-injury history in the current study participated in comparable activities (based on Tegner scores) as their matched healthy controls but had overall a worse perception of their knee health (i.e., more pain, more symptoms, greater difficulty with activities of daily living, greater difficulties in sport and recreational activities, and lower quality of life) as measured by KOOS subscale scores. Unlike previous research that has reported a poor return to physical activity after a knee injury, 6 the participants in this study are largely returning to preinjury levels; however, they are reporting limitations. Ostensibly, these participants with a knee-injury history within this current study are not altering their activity levels despite reporting pain and symptoms that affect their ability to function in sport/physical activity, and, ultimately, their quality of life. In prior research, approximately one-third of individuals with a knee-injury history commonly fail to return to preinjury competitive levels because of their knee symptoms and fear of reinjury, 4,6 but here we found that even those who return to competitive levels are reporting more knee symptoms and lower quality of life than their healthy peers. Although biochemical differences were not found between the two groups, the selfreported outcome differences may be precursors to decreased physical activity or activity modifications. This finding warrants further investigation as it may have implications for possible intervention treatment strategies in the clinical setting to address these patient-reported symptoms.
Pre-exercise self-reported outcomes correlated with biomarker changes. A moderate negative correlation existed between physical activity level and collagen turnover changes pre-to post-exercise. Regardless of knee injury history status, participants with a lower Tegner activity level had greater CTX-II/CPII ratio increases after the 30-min running bout. CTX-II is a catabolic marker indicative of type II collagen degradation, and CP-II is an anabolic marker indicative of type II collagen synthesis. 19 The higher CTX-II/CPII ratio indicates a deviation from joint metabolism homeostasis where there is greater collagen degradation than synthesis. 19, 20 This finding has not previously been reported and provides support to the notion that high functioning participants have less biochemical disturbances in response to an acute bout of moderate intensity running than those who are not as highly physically active. The findings of this study may provide some support to previous findings in a soccer cohort where resting serum COMP levels positively correlated with Lysholm activity scores from mid-to post-season time points. 18 We also found a moderate negative correlation between KOOS quality-of-life score and inflammation (serum IL-1b concentration) change pre-to post-exercise. Participants with lower KOOS quality-of-life scores had greater IL-1b increases pre-to post-exercise. There is evidence that demonstrates an adverse cyclic association between negative emotional states and increased systemic inflammation. 21 IL-1b, and the IL-1 family, are common markers recognized as inflammatory mediators, and they can respond locally or systemically. 22 Further research should investigate the correlations of quality-oflife scores with other inflammatory markers, such as tumor necrosing factor-a or interleukin-6, which have been previously reported to be elevated after marathon running. 10 More research is needed to determine whether inflammatory changes cause quality-of-life issues, whether the quality of life issues cause the inflammatory changes, or whether there is another factor influencing changes in inflammation and quality of life.
The findings of the current study must be interpreted within the context of several methodological limitations. An important consideration is the external generalizability of these findings due to a possible dose-dependent response of biomarkers to exercise. The running bout prescribed in this study was tolerated, and may not have been demanding enough to adversely affect serum biomarker response post exercise within the target population. Another limitation is that the restricted biomarker panel and that all biomarkers were collected through serum sampling. Biospecimens from other sources, such as synovial fluid, tissue samples, or urine, would conceptually allow for a more thorough understanding of pathophysiology post-knee injury and aid in the timing and detection of biomarkers. Lastly, another limitation was the sample size of the study, as the power calculation was conducted for a different purpose. A larger sample size and varied exercise load would be beneficial in understanding the potential clinical implications of the relationship between patient reported outcomes and biomarker changes.
CONCLUSION
Individuals with a knee injury history reported lower quality of life, more pain, and increased difficulties with activities of daily living/physical activity than their healthy, matched controls. Individuals with lower activity levels and lower quality of life experienced greater increases in collagen turnover and OUTCOMES AND RUNNING BIOMARKER CHANGES inflammation after a running bout, respectively. This may indicate that a moderate running stimulus is tolerated by some individuals but not by those who have a lower quality of life or participate in less demanding physical activities (e.g., jogging, cycling). Accordingly, individuals' biomarkers responses to exercise may be dose-dependent. Future research should determine whether individuals trying to start new vigorous activities (e.g., return to previous activity levels after an injury) need to gradually increase the frequency, intensity, and/or duration of activity to avoid aberrant biomarker changes. Furthermore, we need a better understanding of how lower quality of life relates to changes in inflammation after activity. We need to address quality of life in treatment protocols because lower quality of life could lead to unhealthy changes in lifestyle behaviors (e.g., decreased physical activity, weight gain) and have negative long-term effects. Post-knee injury, pathophysiology is complex, and while many studies have evaluated biomarkers among individuals after an injury, this study demonstrates that changes in biomarkers after physical activity may also expand our understanding of the long-term implications of joint injuries.
PRACTICAL IMPLICATIONS
People with an injury history are reporting poor selfreported outcomes despite being cleared by a physician and returning to physical activity.
Pre-exercise self-reported outcomes may be able to be used to identify people at risk for abnormal biomarker responses to running. Intervention programs targeted at quality of life or activity levels may have implications on biomarker joint metabolism in response to a running bout.
